Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) EV to EBIT (2014)

Updated

Xtl Biopharmaceuticals' (XTLB) EV to EBIT stood at 1186.61 in the quarter ended Jun 30, 2014.

Analysis

Xtl Biopharmaceuticals (XTLB) EV to EBIT (2014) Analysis & Trends

On a TTM basis, Xtl Biopharmaceuticals' EV to EBIT came in at 1167.46 as of Jun 30, 2014.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 1,186.61
API Access

Xtl Biopharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=XTLB&period=max&api_key=YOUR_API_KEY